John R Fischer

BayPine sees M&A for digitization of clinical trial recruitment as key to scaling CenExel

“Finding patients for pharma companies and getting them into the trial as quickly as possible is really a key need that these companies are willing to draw on a set of strategic partners to accomplish,” says BayPine's Tom O'Rourke.

Seven deals signal PE’s rising appetite for patient engagement platforms

Private equity is zeroing in on healthtech investments that focus on technology-driven patient support.

Aquiline, Capstreet, Oakley target healthcare insurance; Medline files IPO, backed by H&F, Carlyle, Blackstone

A five-deal listicle on private equity investments in the healthcare insurance sector; a look at an IPO filed this week by a healthcare distribution company backed by Hellman & Friedman, The Carlyle Group and Blackstone; a brief recap of the launch of a new healthcare growth-equity firm announced this week and involving MPowered Capital.

Healthcare insurance pulls in PE: 5 deals

Aquiline Capital Partners, Capstreet, Cypress Ridge and Oakley Capital are targeting investments in the healthcare insurance sector.

CCMP Growth, Little John & Co, Platinum Equity busy in outdoor living; Verite backs renewable fuel producer; Blue Point portco makes fall protection add-on

A look at a few investments from the outdoor living and systems space; Verite Capital Partners agrees to provide $300 million in funding to a used-cooking-oil recycler and renewable green energy fuel producer; National Safety Apparel, a portfolio company of Blue Point Capital Partners, has acquired Gemtor, a provider of fall protection and rescue equipment.

Why Durational Capital invested in Travis Kelce-backed Garage Beer; Archimed, Ardian, Webster among investors in therapeutic pharma manufacturing

Industry insights from the McDermott, Will & Schulte HPE NYC 2025 Conference on what’s driving (and challenging) PE healthcare investing heading into 2026; a look at a $200 million investment made by GTCR in a dental products company; a deep dive on Durational Capital Management’s investment in a beer brand with a creative marketing strategy involving Travis and Jason Kelce.

PE dives into therapeutic drug manufacturing: 5 deals

Archimed, Ardian and Webster Equity Partners are among the PE firms targeting assets in the therapeutic drug manufacturing sector.

Bain’s exit returns aided $14bn fundraise; Platinum Equity scores $375m carve-out from Owens & Minor

Looking at the closing of Bain’s $14 billion flagship fund following one of the largest distribution years in the firm’s history; a $375 million healthcare carve-out deal between Platinum Equity and Owens & Minor; insights from a Deloitte report on PE’s growing use of generative AI and the role it’s playing in dealmaking.

GPs embrace the animal health sector

The pet care industry has become a sweet spot for consumer dealmaking.

What kind of healthcare company will Bill Mixon lead and Waud Capital invest in next?

Mixon led Advanced Diabetes Supply Group, which Court Square sold to Cardinal Health for approximately $1.1bn in cash earlier this year.